Identification of Leishmania proteins preferentially released in infected cells using change mediated antigen technology (CMAT).

by Peter E Kima, J Alfredo Bonilla, Eumin Cho, Blaise Ndjamen, Johnathan Canton, Nicole Leal, Martin Handfield
Published 2010-10-01

OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infections.

by Johan A Kers, Anthony W DeFusco, Jae H Park, Jin Xu, Mark E Pulse, William J Weiss, Martin Handfield
Published 2018-01-01

Role of the ATM-checkpoint kinase 2 pathway in CDT-mediated apoptosis of gingival epithelial cells.

by Mounia Alaoui-El-Azher, Jeffrey J Mans, Henry V Baker, Casey Chen, Ann Progulske-Fox, Richard J Lamont, Martin Handfield
Published 2010-07-01

Mutacin 1140 Lantibiotic Variants Are Efficacious Against Clostridium difficile Infection

by Johan A. Kers, Robert E. Sharp, Anthony W. Defusco, Jae H. Park, Jin Xu, Mark E. Pulse, William J. Weiss, Martin Handfield
Published 2018-03-01

Application of in vivo induced antigen technology (IVIAT) to Bacillus anthracis.

by Sean M Rollins, Amanda Peppercorn, John S Young, Melissa Drysdale, Andrea Baresch, Margaret V Bikowski, David A Ashford, Conrad P Quinn, Martin Handfield, Jeffrey D Hillman, C Rick Lyons, Theresa M Koehler, Stephen B Calderwood, Edward T Ryan
Published 2008-03-01